Sign Up to like & get
recommendations!
1
Published in 2019 at "Neuropharmacology"
DOI: 10.1016/j.neuropharm.2019.04.019
Abstract: Ketamine is a rapid-onset antidepressant whose efficacy long outlasts its pharmacokinetics. Multiple studies suggest ketamine's antidepressant effects require increased α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-dependent currents, which have recently been exclusively attributed to its N-methyl-d-aspartate receptor-inactive metabolite…
read more here.
Keywords:
hnk concentrations;
clinically antidepressant;
ketamine;
pharmacological evaluation ... See more keywords